COSMOS Pharmaceutical Corporation (TYO:3349)

COSMOS Pharmaceutical Revenue

COSMOS Pharmaceutical had revenue of 264.78B JPY in the quarter ending November 30, 2025, with 8.47% growth. This brings the company's revenue in the last twelve months to 1.04T, up 4.84% year-over-year. In the fiscal year ending May 31, 2025, COSMOS Pharmaceutical had annual revenue of 1.01T with 4.81% growth.

• Revenue (ttm): 1.04T
• Revenue Growth: +4.84%
• P/S Ratio: 0.51
• Revenue / Employee: 182.63M
• Employees: 5,709
• Market Cap: 533.24B

Revenue History

Fiscal Year End	Revenue	Change	Growth
May 31, 2025	1.01T	46.40B	4.81%
May 31, 2024	964.99B	137.29B	16.59%
May 31, 2023	827.70B	72.28B	9.57%
May 31, 2022	755.41B	28.99B	3.99%
May 31, 2021	726.42B	42.02B	6.14%